Drug Profile

Sincalide injection - MAIA Pharmaceuticals

Alternative Names: Kinevac

Latest Information Update: 11 Aug 2023

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator MAIA Pharmaceuticals
Class Gastrointestinal hormones; Peptides
Mechanism of Action Cholecystokinin receptor modulators

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

Highest Development Phases

Registered Gallbladder disorders; Intestinal obstruction; Pancreatic disorders

Most Recent Events

11 Aug 2023 First Generic equivalent available in USA used in magnetic resonance imaging (MRI) procedures
21 Nov 2022 Registered for Gallbladder disorders in USA (IV)
21 Nov 2022 Registered for Intestinal obstruction in USA (IV)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com